Debt-to-equity of Iterum Therapeutics plc from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Iterum Therapeutics plc quarterly Debt-to-equity in % history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Iterum Therapeutics plc Debt-to-equity for the quarter ending 30 Sep 2025 was -905%, a 185% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Iterum Therapeutics plc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -905% -588% -185% 30 Sep 2025
Q2 2025 -679% -81% -14% 30 Jun 2025
Q1 2025 -471% +6489% +93% 31 Mar 2025
Q4 2024 -389% -1047% -159% 31 Dec 2024
Q3 2024 -317% -592% -215% 30 Sep 2024
Q2 2024 -598% -784% -422% 30 Jun 2024
Q1 2024 -6959% -7080% -5832% 31 Mar 2024
Q4 2023 658% +562% +589% 31 Dec 2023
Q3 2023 275% +190% +225% 30 Sep 2023
Q2 2023 186% +106% +133% 30 Jun 2023
Q1 2023 121% +30% +33% 31 Mar 2023
Q4 2022 95% -31% -25% 31 Dec 2022
Q3 2022 85% -253% -75% 30 Sep 2022
Q2 2022 80% +1190% 30 Jun 2022
Q1 2022 91% +358% 31 Mar 2022
Q4 2021 127% +294% 31 Dec 2021
Q3 2021 337% +510% 30 Sep 2021
Q2 2021 -1110% -884% -392% 30 Jun 2021
Q1 2021 -266% +243% +48% 31 Mar 2021
Q4 2020 -168% -573% -141% 31 Dec 2020
Q3 2020 -173% -287% -252% 30 Sep 2020
Q2 2020 -226% -281% -510% 30 Jun 2020
Q1 2020 -509% -543% -1608% 31 Mar 2020
Q4 2019 406% 31 Dec 2019
Q3 2019 114% 30 Sep 2019
Q2 2019 55% 30 Jun 2019
Q1 2019 34% 31 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.